Health Condition 1: M069- Rheumatoid arthritis, unspecified
Conditions
Interventions
Intervention1: Individualized Homoeopathic Medicines: 4 pills (BD), Oral route of administration for 15 days, Dosage frequency from baseline till 3 months.
Control Intervention1: Not applicable: Not a
Sponsors
Noble Homoeopathic College and Research Institute
Eligibility
Inclusion criteria
Inclusion criteria: Cases with Anti CCP above 20IU/ml or cases fulfilling the diagnostic criteria of rheumatoid arthritis. Patients who had definite or classical RA, were seropositive for rheumatoid factor and were receiving either stable doses of single non-inflammatory drugs (NSAIDs) for more than 3 months or single disease-modifying anti-rheumatic drugs (DMARDs) with or without NSAIDs for more than 6 months. Fully diagnosed case with adequate investigations
Exclusion criteria
Exclusion criteria: Patients who were severely disabled, had taken systemic steroids in the previous 6 months or had withdrawn from DMARD therapy in the previous 12 months were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess changes in reducing the symptoms of joint inflammation in rheumatoid arthritis by RASS through individualized homoeopathic treatment. Timepoint: Baseline, 4 weeks, 12 weeks, till 6th month | — |
Secondary
| Measure | Time frame |
|---|---|
| To shortlist the commonly indicated homoeopathic medicines. To access weather any benefits from adjunctive homoeopathic intervention in patients with rheumatoid arthritis are due to homoeopathic remedies. Timepoint: Baseline, 4 weeks, 12 weeks, till 6th month | — |
Countries
India
Contacts
Public ContactAditya Dilipkumar Patil
Noble Homoeopathic College and Research Institute
Outcome results
None listed